Cedilla
Alan D'Andrea has worked at Cedilla Therapeutics since 2018, where they serve as Co-Founder. Prior to this, they were a Professor at Dana-Farber Cancer Institute from 1986.
Alan D'Andrea obtained their MD degree from Harvard Medical School between 1979 and 1983, studying Medicine.
This person is not in any teams
This person is not in any offices
Cedilla
Cedilla is developing novel small-molecule therapeutics directed to unrecognized allosteric binding sites, providing new ways to target key cancer drivers and treat life threatening diseases.